Stay updated on Dolutegravir vs Lopinavir/Ritonavir in Second-line Clinical Trial

Sign up to get notified when there's something new on the Dolutegravir vs Lopinavir/Ritonavir in Second-line Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Dolutegravir vs Lopinavir/Ritonavir in Second-line Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    Page revision updated from v3.4.2 to v3.4.3, indicating a minor administrative update.
    Difference
    0.0%
    Check dated 2026-03-05T18:32:08.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    32 days ago
    Change Detected
    Summary
    Revision updated from v3.4.1 to v3.4.2; no study details or user-facing content appear changed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-12T04:09:32.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    Revision updated from v3.4.0 to v3.4.1. This appears to be a minor version update.
    Difference
    0.0%
    Check dated 2026-02-05T02:19:50.000Z thumbnail image
  6. Check
    47 days ago
    Change Detected
    Summary
    The page added a 'Show glossary' option and new labels such as 'Last Update Submitted that Met QC Criteria' and 'Revision: v3.4.0', and removed older phrasing including 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4'. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-28T22:18:57.000Z thumbnail image
  7. Check
    54 days ago
    Change Detected
    Summary
    Revision: v3.3.4 is now displayed, replacing the previous v3.3.3. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-21T18:14:37.000Z thumbnail image
  8. Check
    84 days ago
    Change Detected
    Summary
    Added a centralized Locations section listing trial sites in Buenos Aires, Santa Fe Province, Estado de Bahia, São Paulo, Região Metro de Santiago, Guangdong, Jalisco, and Gauteng, and removed the previous 'X Locations' subsections. Updated the page revision to v3.3.3.
    Difference
    0.6%
    Check dated 2025-12-22T22:59:09.000Z thumbnail image

Stay in the know with updates to Dolutegravir vs Lopinavir/Ritonavir in Second-line Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Dolutegravir vs Lopinavir/Ritonavir in Second-line Clinical Trial page.